Request for Funding
Grants and Donations
‘Grants and Donations’ collectively mean providing funds, benefits-in-kind or services freely given for the purpose of supporting healthcare, scientific research or education, with no consequent obligation to provide any benefit to CSL in return. Donations and grants do not constitute an inducement to recommend and/or prescribe, purchase, supply, sell or administer specific medicines. Donations and grants to individuals are prohibited.
In general, donations are physical items, services or benefits-in-kind which may be offered or requested. Grants are the provision of funds.
All grants and donations provided by CSL UK will be publicly disclosed annually.
Investigator-initiated study (IIS)
An Investigator-initiated study (IIS) is a study conceived, initiated, sponsored, and conducted independently by a non-CSL sponsor, such as an investigator, healthcare institution, university, research network, or professional association. The sponsor retains full responsibility for study design, conduct, management, regulatory compliance, and reporting in accordance with all applicable laws, regulations, and ethical standards.
Proposals are reviewed for scientific merit, feasibility, and alignment with CSL’s research objectives. Applicants will be notified of the review outcome. Where a concept is of interest, investigators may be invited to submit a full protocol and supporting documentation for further evaluation.
Patient Organisation Grants
CSL provides grant funding to patient organisations as essential partners in advancing meaningful, sustainable improvements in awareness, advocacy, education, patient care and outcomes across our disease areas of interest and rare diseases. These grants may be used for activities delivered by patient organisations alone or in partnership with healthcare institutions and professional societies. Examples include educational events, patient meetings, workshops, training sessions, and other initiatives that contribute to improved patient advocacy, knowledge, empowerment, and outcomes.
Learn more
UK-NA-2600052 June 2026